英文字典中文字典


英文字典中文字典51ZiDian.com



中文字典辞典   英文字典 a   b   c   d   e   f   g   h   i   j   k   l   m   n   o   p   q   r   s   t   u   v   w   x   y   z       







请输入英文单字，中文词皆可：


请选择你想看的字典辞典：
单词字典翻译
Gilead查看　Gilead　在百度字典中的解释百度英翻中〔查看〕
Gilead查看　Gilead　在Google字典中的解释Google英翻中〔查看〕
Gilead查看　Gilead　在Yahoo字典中的解释Yahoo英翻中〔查看〕

安装中文字典英文字典查询工具!


中文字典英文字典工具:
选择颜色:
输入中英文单字

































































英文字典中文字典相关资料:


  • Gilead Sciences
    Gilead Sciences, a biopharma company, achieves bold ambitions to help make the world a healthier place, leading in HIV, liver disease, cancer inflammation
  • Gilead Sciences: Company
    Learn about the biopharmaceutical company Gilead Sciences, including mission, vision, values, history, impact, leadership, therapeutic areas and other information
  • Gilead Sciences Announces Fourth Quarter and Full Year 2024 Financial . . .
    “Gilead delivered another exceptionally strong full year and fourth quarter, with growth in our base business product sales of 8% for 2024 and 13% year-over-year for the fourth quarter,” said Daniel O’Day, Gilead’s Chairman and Chief Executive Officer
  • Medicines - Gilead Sciences
    Access the list of approved Gilead therapies across virology including HIV, liver disease including hepatitis and primary biliary cholangitis, oncology inflammation
  • U. S. FDA Accepts Gilead’s New Drug Applications for Twice-Yearly . . .
    Gilead researchers have developed 12 HIV medications, including the first single-tablet regimen to treat HIV, the first antiretroviral for pre-exposure prophylaxis (PrEP) to help reduce new HIV infections, and the first long-acting injectable HIV treatment medication administered twice-yearly
  • Gilead U. S. Investment to Create $43 Billion in Value to U. S. Economy
    This comprehensive investment further bolsters Gilead’s domestic research, development, and manufacturing capabilities while advancing the company’s mission to discover and develop life-changing medicines
  • Virology, Inflammation, Oncology Pipeline | Gilead
    Through science and innovative partnerships, Gilead expands research and development programs in virology, oncology, inflammation Learn about our pipeline
  • First Clinical Data for Gilead’s Investigational Once-Yearly . . .
    Gilead researchers have developed 12 HIV medications, including the first single-tablet regimen to treat HIV, the first antiretroviral for pre-exposure prophylaxis (PrEP) to help reduce new HIV infections, and the first long-acting injectable HIV treatment medication administered twice-yearly
  • Newsroom | Gilead
    This is our global website, intended for visitors seeking information on Gilead’s worldwide business Some content on this site is not intended for people outside the United States Visit our Global Operations page for links to our international corporate websites
  • Gilead Sciences, Inc. - Gilead Sciences Announces Fourth Quarter and . . .
    As of December 31, 2024, Gilead had $10 0 billion of cash, cash equivalents and marketable debt securities compared to $8 4 billion as of December 31, 2023 During the fourth quarter 2024, Gilead generated $3 0 billion in operating cash flow





中文字典-英文字典  2005-2009